SYF24a8e521622e4872a1817e541557117bRegistry ID: 2024-517095-38-00|RecruitingPhase 2/3
Imaging multiple myeloma patients in the REMNANT study with Fluciclovine PET/CT (FLUCIPET)
Oslo University Hospital HF
Loading search results
interventional
N/A
1 country
1
To detect the number of patients in the REMNANT study who are positive with Fluciclovine PET/CT and negative with FDG PET/CT and determine how this correlate to PFS and OS
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 15, 2024
Actual (reported)The number of patients with positive Fluciclovine PET/CT and negative FDG PET/CT and how this correlate to PFS and OS
The number of patients with positive Fluciclovine PET/CT and positive FDG PET/CT and how this correlate to PFS and OS
The number of patients with negative Fluciclovine PET/CT and positive FDG PET/CT and how this correlate to PFS and OS
The number of patients with negative Fluciclovine PET/CT and negative FDG PET/CT and how this correlate to PFS and OS
Evaluate the safety of Fluciclovine, by incidence and severity of AEs
Determine the agreement between Fluciclovine PET/CT and FDG PET/CT assessments
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Oslo University Hospital HF
Oslo, 0450, Norway
Caroline Stokke
First Submitted
October 15, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)
Contact the study team to confirm eligibility.